Small molecules, the traditional active ingredients in pharmaceuticals, continue to drive growth within the industry as potent catalysts for innovation. According to IMS research, these chemically produced microscopic entities constitute 53% of the global oncology market, surpassing biologics which now account for 47%.

Apart from active pharmaceutical ingredients, SRP Laboratories specializes in providing custom synthesis services for a diverse array of small molecules, including pharmaceutical intermediates, drug metabolites, and analytical standards. Our expertise extends from milligram to multi-kilogram scale synthesis, ensuring a comprehensive range of fine chemicals for small molecule drug discovery.

Custom synthesis plays a pivotal role in small molecule medication research and screening, with our modern analytical laboratories equipped to devise procedures yielding materials exceeding 98% HPLC purity. Our adaptable approach enables us to meet your precise quality standards, whether your project necessitates milligram or kilogram volumes. We thrive on challenging synthesis assignments and prioritize swift responsiveness to your needs.